IRLAB to present at Redeye Life Science Day 2022

November 24, 2022

Gothenburg, Sweden, November 24, 2022 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most troublesome symptoms of Parkinson’s disease, today announced that the company will present and participate at Redeye Life Science Day 2022 on Thursday, November 24, 2022.

[mfn_before_post]

Gothenburg, Sweden, November 24, 2022 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most troublesome symptoms of Parkinson’s disease, today announced that the company will present and participate at Redeye Life Science Day 2022 on Thursday, November 24, 2022.

Richard Godfrey, CEO, will participate in an interview segment at 11:40 CET on Thursday, November 24, 2022. A pre-recorded company presentation is available via the event platform. Follow the live broadcast at https://www.redeye.se/events/850947/redeye-life-science-day.
 
A recording of the interview and presentation will be made available on our company website, www.irlab.se, following the event.

[mfn_after_post]